TY - JOUR T1 - Clinicopathological Analysis of Non-B Non-C Hepatocellular Carcinoma Focusing on Cellular Proliferation JF - Anticancer Research JO - Anticancer Res SP - 449 LP - 457 DO - 10.21873/anticanres.15503 VL - 42 IS - 1 AU - SHINJI MIZUOCHI AU - JUN AKIBA AU - REIICHIRO KONDO AU - HIRONORI KUSANO AU - TARO SHIOGA AU - KEIICHI KONDO AU - KANA TSUTSUI AU - MASAMICHI NAKAYAMA AU - SACHIKO OGASAWARA AU - YOSHIKI NAITO AU - OSAMU NAKASHIMA AU - HIROHISA YANO Y1 - 2022/01/01 UR - http://ar.iiarjournals.org/content/42/1/449.abstract N2 - Background/Aim: Non-B non-C hepatocellular carcinomas (NBNC-HCCs) are larger than hepatitis virus-related HCCs. We conducted a clinicopathological study of patients who underwent curative NBNC-HCC resection, including proliferative activity assessments, such as nuclear grade and Ki-67 labelling index (LI). Materials and Methods: Histopathological findings of 197 patients were examined, including 56 NBNC-HCCs, 45 hepatitis B virus (HBV)-related HCCs (HBV-HCC), and 96 hepatitis C virus (HCV)-related HCCs (HCV-HCC). Results: NBNC-HCCs were significantly larger than HCV-HCCs, but not significantly different from HBV-HCCs. Mitotic counts, nuclear grade, and Ki-67 LI of NBNC-HCCs were not significantly different from those of HCV-HCCs, but were significantly lower than those of HBV-HCCs. Recurrence-free survival was significantly better in the NBNC-HCC group than in the HBV-HCC group in cases with mild liver fibrosis. Conclusion: NBNC-HCCs were significantly larger in diameter, but their nuclear grade or Ki-67 LI were not significantly different from those of other HCCs, suggesting that they do not have a higher proliferative activity. ER -